Accidente cerebrovascular criptogénico

Referencias

1. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-90.

2. Li L, Yiin GS, Geraghty OC, et al. Incidence, outcome, risk factors, and longterm prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 2015; 14: 903-13.

3. Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 2013; 70: 51-7.

4. Wolf ME, Grittner U, Böttcher T, Norrving B, Rolfs A, Hennerici MG. Phenotypic ASCO characterisation of young patients with ischemic stroke in the prospective multicentre observational sifap1 study. Cerebrovasc Dis 2015; 40: 129-35.

5. Bogousslavsky J, Caplan LR, eds. Uncommon causes of stroke. 2nd ed. Cambridge, United Kingdom: Cambridge University Press, 2008.

6. Saver JL, Tamburi T. Genetics of cerebrovascular disease. In: Pulst S-M, ed. Neurogenetics. Oxford, United Kingdom: Oxford University Press, 1999: 403-31.

7. Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014; 13: 429-38.

8. Paciaroni M, Agnelli G, Caso V, et al. Atrial fibrillation in patients with firstever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost 2005; 3: 1218-23.

9. Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging 2012; 5: 397-405.

10. Scullen TA, Monlezun DJ, Siegler JE, et al. Cryptogenic stroke: clinical consideration of a heterogeneous ischemic subtype. J Stroke Cerebrovasc Dis 2015; 24: 993-9.

11. Mas J-L, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-6.

12. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105: 2625-31.

13. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol 2003; 54: 227-34.

14. Knebel F, Masuhr F, von Hausen W, et al. Transesophageal echocardiography in patients with cryptogenic cerebral ischemia. Cardiovasc Ultrasound 2009; 7: 15.

15. Rus Mansilla C, Mesa Rubio D, Suárez de Lezo Cruz Conde J, Rodríguez Almodovar A, Durán Torralbo C, Delgado Ortega M. Utility of transesophageal echocardiography in young patients with cryptogenic stroke and low cardiovascular risk. Med Clin (Barc) 2008; 130: 241-5. (In Spanish.)

16. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

N Engl J Med 2013; 368: 1092-100.

17. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial — TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.

18. Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000; 31: 1081-9.

19. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping). Cerebrovasc Dis 2013; 36: 1-5.

20. Arsava EM, Ballabio E, Benner T, et al. The Causative Classification of Stroke system: an international reliability and optimization study. Neurology 2010; 75:1277-84.

21. Marnane M, Duggan CA, Sheehan OC, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin Population Stroke Study. Stroke 2010; 41: 1579-86.

22. Chatzikonstantinou A, Wolf ME, Hennerici MG. Ischemic stroke in young adults: classification and risk factors. J Neurol 2012; 259: 653-9.

23. Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack:a systematic review and meta-analysis. Lancet Neurol 2015; 14: 377-87.

24. Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2012; 21:89-93.

25. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-9.

26. Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke prevention Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 2014; 35: 508-16.

27. Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370: 2478-86.